Kłusek, M., K. Chawrylak, J. Kuszneruk, M. Kubas, and K. Krzemińska. “Sodium–glucose Co-Transporter-2 Inhibitors - Empagliflozin and Dapagliflozin As Future Therapy for Alport Syndrome, Literature Review”. Quality in Sport, vol. 18, July 2024, p. 53252, doi:10.12775/QS.2024.18.53252.